Publications by authors named "Hirotoshi Ota"
Article Synopsis
- The study evaluated the ID NOW™ COVID-19 2.0 test for detecting SARS-CoV-2, which can provide results in just 12 minutes.
- A total of 38 positive and 46 negative samples were analyzed, revealing a sensitivity of 94.7% and a specificity of 100% for the ID NOW™ 2.0.
- Despite Japan relaxing COVID-19 restrictions, the ID NOW™ 2.0 is considered a promising rapid and reliable testing alternative to traditional RT-PCR methods.
Background: Cancer patients are at high risk of developing a second cancer after the treatment of initial cancers. Understanding the characteristics of multiple primary cancer is important to establish an effective surveillance program for the early detection of second cancers.
Methods: We analyzed the cancer registry records from 1986 to 1995 at the Cancer Institute Hospital.